Anhui Zhifei Longcom Biologic Pharmacy
CompanyChina
Anhui Zhifei Longcom Biologic Pharmacy develops 2 assets, the furthest in phase 3 (FLU-v in influenza). Mostly vaccine acting on inflammation; based in China.
- 2
- Assets
- Furthest stage
- Phase 3
- 1
- Trial
- 0
- Signals
Pipeline
2Inactivated influenza virus vaccine inducing protective antibody responses
Phase 3, Vaccine, Inflammation, influenza, influenza immunization
Influenza Vaccine (Split Virion), Inactivated, Quadrivalent, ZFA02 Adjuvant
Adjuvanted quadrivalent inactivated split-virion influenza vaccine generating immune response against influenza viruses
Phase 1, Vaccine, human influenza
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms2
- Trials1
- Similar companies6